Can adenosine A2A receptor antagonists be used to treat cognitive impairment, depression or excessive sleepiness in Parkinson's disease?
Peter Jenner, Akihisa Mori, Tomoyuki Kanda
Topics & Concepts
Parkinson's diseaseDepression (economics)Cognitive impairmentMedicineAdenosine A2A receptorDiseaseAdenosineCognitionPsychiatryPsychologyNeuroscienceAdenosine receptorReceptorInternal medicinePharmacologyAgonistMacroeconomicsEconomicsAdenosine and Purinergic SignalingParkinson's Disease Mechanisms and TreatmentsVagus Nerve Stimulation Research